Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging viral infection causing coronavirus disease 2019 (COVID-19). Hydroxychloroquine and chloroquine have garnered unprecedented attention as potential therapeutic agents against COVID-19 following several small clinical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastick, Katelyn A, Okafor, Elizabeth C, Wang, Fan, Lofgren, Sarah M, Skipper, Caleb P, Nicol, Melanie R, Pullen, Matthew F, Rajasingham, Radha, McDonald, Emily G, Lee, Todd C, Schwartz, Ilan S, Kelly, Lauren E, Lother, Sylvain A, Mitjà, Oriol, Letang, Emili, Abassi, Mahsa, Boulware, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184359/
https://www.ncbi.nlm.nih.gov/pubmed/32363212
http://dx.doi.org/10.1093/ofid/ofaa130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184359/
https://www.ncbi.nlm.nih.gov/pubmed/32363212
http://dx.doi.org/10.1093/ofid/ofaa130

Ejemplares similares